WebACTEMRA Access Solutions works with your healthcare provider and health insurance company and specialty pharmacy to help you get your medicine. If you are eligible, options to help you pay for ACTEMRA may include*: ACTEMRA Co-pay Program; Referrals to independent co-pay assistance foundations; The Genentech Patient Foundation WebJan 19, 2024 · Actemra subcutaneous formulations (ACTPen® and pre-filled syringe) continue to be available for patients prescribed Actemra for FDA-approved indications, …
Genentech Announces FDA Approval of Clinical Trial for …
WebAug 17, 2024 · Genentech and Roche Holdings AG's RHHBF drug Actemra, or tocilizumab, was granted FDA emergency use authorization for critically ill COVID-19 patients after showing it cut the risk of death. WebACTEMRA® (tocilizumab) intravenous (IV) infusion SIG: Infuse: mg Once every 2 weeks Once every 4 weeks Other: Dispense ACTEMRA vials: 80-mg dose 200-mg dose 400-mg dose Patient weight: lbs Refill times ACTEMRA subcutaneous (SC) self-injectable Prefilled syringe Autoinjector (ACTPen®) nature\\u0027s boost blood formula shark tank
Prescriber Service Form for ACTEMRA - genentech …
Actemra was the first humanized interleukin-6 (IL-6) receptor antagonist approved for the treatment of adult patients with moderately to severely active rheumatoid arthritis (RA) who have used one or more disease-modifying antirheumatic drugs (DMARDs), such as methotrexate (MTX), that did not provide … See more AUTHORIZED USE ACTEMRA is authorized for emergency use under an Emergency Use Authorization (EUA) for the treatment of COVID-19 in hospitalized adults and pediatric patients (2 years of age and older) who … See more Founded more than 40 years ago, Genentech is a leading biotechnology company that discovers, develops, manufactures and commercializes medicines to treat … See more WebJul 29, 2024 · Actemra intravenous solution for injection, Genentech, 20 mg/mL, 4 mL vial, NDC 50242-0135-01. Actemra subcutaneous solution for injection, Genentech, 162 mg/0.9 mL, prefilled syringe, NDC 50242-0138-01. Actemra ACTPen subcutaneous solution for injection, Genentech, 162 mg/0.9 mL, prefilled syringe, NDC 50242-0143-01. WebNov 25, 2024 · According to a statement by Genentech, the drug’s manufacturer, there will most likely be continued shortages throughout the pandemic. At one point during the summer of 2024, Genentech reported a “temporary stockout” of Actemra IV in the U.S. because so much of it was being used for covid patients. marine weather lake erie ontario